Methamphetamine Hydrochloride

FDA Drug Profile — Methamphetamine Hydrochloride

Methamphetamine Hydrochloride is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including Methamphetamine Hydrochloride. Available dosage forms: tablet, powder.

Drug details

Generic Name
Methamphetamine Hydrochloride
Brand Names
Methamphetamine Hydrochloride
Application Number
ANDA203846
Sponsor
Hikma Pharmaceuticals USA Inc.
NDC Codes
2
Dosage Forms
TABLET, POWDER
Routes
ORAL
Active Ingredients
METHAMPHETAMINE HYDROCHLORIDE

Indications and Usage

1. INDICATIONS AND USAGE Methamphetamine hydrochloride tablets, USP is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in pediatric patients 6 years of age and older. Methamphetamine hydrochloride tablets, USP is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in pediatric patients 6 years of age and older.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.